Higher
Blood Sugar Levels linked to lower Brain
Function in Diabetics
Newswise — Results of a recent study
conducted by researchers at Wake Forest
University Baptist Medical Center and
colleagues show that cognitive functioning
abilities drop as average blood sugar levels
rise in people with type 2 diabetes.
The study appears in this month’s issue of
Diabetes Care.
The ongoing Memory in Diabetes (MIND) study,
a sub-study of the Action to Control
Cardiovascular Risk in Diabetes Trial
(ACCORD), found a statistically significant
inverse relationship between A1C levels
(average blood glucose levels over a period
of two to three months) and subjects’ scores
on four cognitive tests.
No
association, however, was found between
daily blood glucose levels (measured by the
fasting plasma glucose test) and test
scores.
For the study, researchers at 52 of the 77
ACCORD sites throughout the United States
and Canada administered a 30-minute battery
of cognitive tests to nearly 3,000
individuals ages 55 years and older.
“The tests used in the study measured
several aspects of memory function,” said
Jeff Williamson, M.D., M.H.S., principal
investigator for the study at the Wake
Forest clinical site.
“For example, we tested one's ability to
switch back and forth between memory tasks
or to ‘multitask,’ an important skill for
people needing to manage their diabetes.”
The results showed that a 1 percent increase
in A1C corresponded to slightly lower scores
on tests of psychomotor speed, global
cognitive function, memory and multiple task
management.
“One of the little known complications of
type 2 diabetes is memory decline leading to
dementia, particularly Alzheimer's
dementia,” said Williamson, a professor of
internal medicine, director of gerontology
and geriatrics research, and director of the
Roena Kulynych Center for Memory and
Cognition Research at Wake Forest Baptist.
“This study adds to the and that these associations can be
detected well before a person develops
severe memory loss.”
Diabetes is a risk factor for mild cognitive
impairment, vascular dementia and
Alzheimer’s disease.
Previous studies have shown that people with
diabetes are 1.5 times more likely to
experience cognitive decline and develop
dementia than people without diabetes.
The ACCORD-MIND study supports the idea that
the brain’s chronic exposure to elevated
blood glucose levels may be part of the
explanation for this phenomenon.
Alternatively, people with impaired
cognitive ability have higher A1Cs because
they are less compliant in taking
medications and controlling their diabetes.
The ongoing ACCORD-MIND study, which is
overseen by Williamson and a team of Wake
Forest Baptist researchers, will test the
hypothesis that lowering A1C could result in
improved cognitive function.
Meanwhile, “people with type 2 diabetes and
their health care providers need to be
careful in situations where there is
education and teaching about diabetes care,
as patients may need a little more time to
absorb and process information,” Williamson
said.
“Patients also need to be open to having a
family member periodically making sure they
are keeping track of managing their diabetes
through monitoring, diet, exercise and
medication.”
The ACCORD-MIND study was funded by the
National Institute on Aging in collaboration
with the ACCORD trial funded by NHLBI with
additional support from the National
Institute of Diabetes and Digestive and
Kidney Diseases, the National Eye Institute,
the National Institute on Aging and the
Centers for Disease Control and Prevention.
Wake Forest University Baptist Medical
Center (www.wfubmc.edu
) is an academic health system comprised of
North Carolina Baptist Hospital, Brenner
Children’s Hospital, Wake Forest University
Physicians, and Wake Forest University
Health Sciences, which operates the
university’s School of Medicine and Piedmont
Triad Research Park.
The system comprises 1,154 acute care,
rehabilitation and long-term care beds and
has been ranked as one of “America’s Best
Hospitals” by U.S. News & World Report since
1993.
Wake Forest Baptist is ranked 32nd in the
nation by America’s Top Doctors for the
number of its doctors considered best by
their peers.
The institution ranks in the top third in
funding by the National Institutes of Health
and fourth in the Southeast in revenues from
its licensed intellectual property.